Free Trade and Free Taxes: How Our Intellectuals Help the Rich
Since I came to Washington in 1992, I have been working alongside friends in the policy community, labor movement, and community organizations in…
More on Open-Source Versus Patent Monopoly Financing of Drug Development
Open sourcing research would greatly improve the pharmaceutical market for governments and citizens. Dean Baker writes.
How Will Our Children Know They Face a Crushing Debt Burden?
Deficit hawks are sure to be out in droves soon complaining about national debt. But how meaningful is the debt? Dean Baker writes.
The Coronavirus Vaccine Fail and International Elites
Concerning the global failure to reach the working class with vaccines. Dean Baker writes.
Vaccines, Vaccines, Vaccines – Why Doesn’t Everyone Have One or Two?
Preparation is clearly not the American way, even when people are dying. Dean Baker writes.
Waiting for a Vaccine and the Collaborative Research Alternative
America’s intellectual property laws and its jingoism are in the way of vaccine development. Dean Baker writes.
Are Corporate CEOs Worth $20 Million?
If CEOs pay has nothing to do with returns to shareholders, why are they making $20 million? Dean Baker writes.
More Thoughts on the Post-Pandemic Economy
Money doesn’t measure the health of an economy — or a society. Dean Baker writes.
Combatting the Political Power of the Rich: Wealth Taxes and Seattle Election Vouchers
Thoughts from Dean Baker.
